The Convention on Biological Diversity (CBD) has three equally important objectives:
- It protects biological diversity (biodiversity). This includes genetic variety among species, genetic variety within a species, and the diversity of the ecosystem.
- It envisions a sustainable use of the components of biological diversity.
- It regulates access as well as the fair and equitable sharing of benefits arising from the use of genetic resources (access and benefit sharing).
The CBD is an international environmental agreement. It has 196 signatory states, including Switzerland and the European Community. The CBD has already adopted several international treaties for implementing its objectives, including the Nagoya Protocol.
The IPI is part of the delegation representing Switzerland at the CBD Conference of the Parties.
Swiss Biotech Report – biotech industry continues to thrive
EPO announces the finalists for the European Inventor Award 2019
Swiss Youth in Science honours young researchers
The measures introduced to combat “Swissness” misuse yield results
10.04.2019 | Event
The IPI at the Exhibition of Inventions in Geneva from 10 to 14 April 2019 - why not stop by and see us?
Info event on using strategic patent analyses on 11.4.2018 in Zurich